Tulathromycin Patent Expiration
About Veterinary Tulathromycin
Tulathromycin is used in drugs marketed by 10 different companies: Bimeda Animal Health Ltd, Parnell Technologies Pty Ltd, Norbrook Laboratories Ltd, Ceva Sante Animale, Elanco Us Inc, Intervet Inc, Hikma Pharmaceuticals Usa Inc, Virbac Ah Inc, Cronus Pharma Specialities India Private Ltd, Zoetis Inc.
Other drugs containing Tulathromycin are: Macrosyn , Draxxin 25 injectable solution , Increxxa 25 , Tulieve
Veterinary Tulathromycin Patents
Given below is the list of patents protecting Tulathromycin, along with the drug name that holds that patent and the company owning that drug.
| Drug Used In | Drug Patent Number | Drug Patent Expiry | Drug Owner |
|---|---|---|---|
 | |||
| Draxxin 25 Injectable Solution | US6583274 | 02 May, 2020 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6329345 | 18 Nov, 2019 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6420536 | 24 May, 2019 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6777393 | 29 May, 2018 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6936592 | 29 May, 2018 | ZOETIS INC. |
| Draxxin | US6583274 | 02 May, 2020 | ZOETIS INC. |
| Draxxin | US6329345 | 18 Nov, 2019 | ZOETIS INC. |
| Draxxin | US6420536 | 24 May, 2019 | ZOETIS INC. |
| Draxxin | US6777393 | 29 May, 2018 | ZOETIS INC. |
| Draxxin | US6936592 | 29 May, 2018 | ZOETIS INC. |
Tulathromycin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List